ConjugateVaccinePolysaccharideProteinRatio_QualityChecker

Conjugate Vaccine Polysaccharide/Protein Ratio

Huvac human vaccines vaccination adjuvants mRNA vaccines sterility endotoxins cold chain

Utility description: Conjugate Vaccine Polysaccharide/Protein Ratio

Conjugate Vaccine Polysaccharide/Protein Ratio Quality Checker — Control of Polysaccharide/Protein Ratio in Conjugate Vaccines

ℹ️ Utility assesses critical structural parameters of conjugate vaccines (Pneumococcal, Hib, Meningococcal) according to specific monographs and WHO requirements:
• Saccharide/Protein Ratio: Weight ratio of polysaccharide to carrier protein.
• Free Polysaccharide: Percentage of unconjugated saccharide (must be minimal, typically <5%).
• Component Content: Absolute amounts of polysaccharide and protein per dose.
• Carrier Protein: Identification (CRM197, Tetanus Toxoid, Diphtheria Toxoid).

⚠️ CRITICAL:
• High level of free polysaccharide (>5-10%) can induce immune tolerance (Heymann phenomenon), reducing vaccine efficacy upon revaccination.
• Too low Saccharide/Protein ratio means excess protein, increasing side effect risk without improving immunity.
• Too high ratio means insufficient conjugation and poor T-cell antigen presentation.

Usage:
ConjugateVaccinePolysaccharideProteinRatioQualityChecker.exe → demo mode (console output)
ConjugateVaccinePolysaccharideProteinRatioQualityChecker.exe input.csv output.json → evaluate your data

Input format:
BatchNumber,ProductName,SaccharideContent_ug_per_ml,ProteinContent_ug_per_ml,FreePolysaccharide_Percent,MolecularWeight_kDa,CarrierProtein

Example:
CONJ-PCV13-001,Pneumo Serotype 4,2.2,20.0,3.5,450.0,CRM197

— WHY IS THIS NEEDED?
Conjugate vaccines convert a T-independent antigen (bacterial capsule polysaccharide) into a T-dependent one by covalent binding to a protein.
This allows formation of immunological memory in young children.
The quality of this chemical binding (conjugation) directly determines vaccine efficacy.

⚠️ CRITICAL:
• Assay Methods: Polysaccharide is often measured by colorimetric reaction (e.g., anthrone for glucose, orcinol for ribose) or HPLC. Protein by Bradford or Lowry.
• Purification: After conjugation reaction, thorough purification (ultrafiltration, chromatography) is required to remove free saccharide.
• Heterogeneity: Conjugate is a mixture of molecules with different numbers of saccharide chains per protein. Ratio is an averaged parameter.
• Stability: Bond degradation (deconjugation) is possible during storage, so free saccharide control is important in stability studies too.

Key features:
• Calculation of Saccharide/Protein weight ratio
• Control of free impurity levels (Free Polysaccharide)
• Verification of active component content
• Generation of reports for R&D and QC departments, and LIMS LabWare
• Compliance with Ph. Eur. and WHO requirements for conjugate vaccines

Critical parameters:
• S/P Ratio: Typically 0.05 – 0.5 (depends on serotype)
• Free Polysaccharide: < 5.0%
• Saccharide Content: Within product specification
• Protein Content: Within product specification

💡 Usage tips:
1. Method Specificity: Ensure saccharide quantification methods do not cross-react with protein or free sugars from culture medium.
2. Reference Standards: Use internal standards of the specific conjugate batch for calibration.
3. Particle Size: Additionally control conjugate molecule size (Kd or SEC-HPLC) as it correlates with immunogenicity.
4. Process: Conjugation parameters (pH, temperature, activation time) must be strictly fixed as they affect the ratio.
5. Interpretation: If ratio is normal but free saccharide is high, purification process was inefficient.

⚠️ Note: For multivalent vaccines (e.g., PCV13 or MenACWY), this test is performed for each serotype/serogroup separately before bulk blending, as each has its own optimal conjugation parameters.

input.csv

BatchNumber,ProductName,SaccharideContent_ug_per_ml,ProteinContent_ug_per_ml,FreePolysaccharide_Percent,MolecularWeight_kDa,CarrierProtein
CONJ-PCV13-2026-001,Pneumococcal Serotype 4,2.2,20.0,3.5,450.0,CRM197
CONJ-HIB-2026-002,Hib Conjugate,10.0,25.0,2.0,300.0,Tetanus Toxoid
CONJ-MEN-FAIL-003,Meningococcal C,5.0,15.0,8.5,200.0,CRM197

URS & FS — User Requirements and Functional Specification

This document describes the controlled interface and behaviour of ConjugateVaccinePolysaccharideProteinRatio_QualityChecker for Conjugate Vaccine Polysaccharide/Protein Ratio Quality Checker.

Domain limits URS input.csv FS IQ/OQ/PQ

Domain limits and critical parameters

Key fragments from the source description are shown below. Before production use, limits must be verified against the approved specification, registration dossier and local SOPs.

ℹ️ Utility assesses critical structural parameters of conjugate vaccines (Pneumococcal, Hib, Meningococcal) according to specific monographs and WHO requirements:
• Free Polysaccharide: Percentage of unconjugated saccharide (must be minimal, typically <5%).
⚠️ CRITICAL:
• High level of free polysaccharide (>5-10%) can induce immune tolerance (Heymann phenomenon), reducing vaccine efficacy upon revaccination.
• Control of free impurity levels (Free Polysaccharide)
• Compliance with Ph. Eur. and WHO requirements for conjugate vaccines
Critical parameters:
• Free Polysaccharide: < 5.0%
4. Process: Conjugation parameters (pH, temperature, activation time) must be strictly fixed as they affect the ratio.

URS — User Requirements Specification

ID	Requirement	Criticality	Acceptance criterion
URS-001	The utility shall accept an input.csv file for Conjugate Vaccine Polysaccharide/Protein Ratio Quality Checker with headers defined in the data contract.	High	The file is processed without manual header editing.
URS-002	The utility shall perform deterministic QC evaluation without machine learning and without probabilistic conformance decisions.	High	Identical input data, rule version and configuration produce reproducible results.
URS-003	The utility shall validate mandatory fields, data types, ranges, units and domain plausibility.	High	Schema, conversion and range errors are explicitly reported.
URS-004	The utility shall apply domain limits and rules from the description, approved specification, registration dossier and local SOPs.	High	Each check has PASS/WARNING/FAIL and a clear message.
URS-005	The utility shall generate output.json with machine-readable results, source values, warnings, failures and critical findings.	High	JSON is suitable for LIMS/ELN/MES integration and QA/QC review.
URS-006	The utility shall preserve traceability between batch/sample, input file, applied rules and final status.	High	Output contains identifiers, checked parameters and audit metadata.
URS-007	The documentation shall support IQ/OQ/PQ, CSV/CSA and review by internal QA or inspectors.	Medium	URS, FS, input/output contract and test scenarios are supplied with the utility.
URS-008	The utility shall be used as a QC decision-support tool and not as a substitute for approved specifications and QA/QP release decision.	Medium	Documentation states change control and limit-verification expectations.

input.csv contract

#	Field	Type	Sample	Purpose
1	`BatchNumber`	string / controlled vocabulary	`CONJ-PCV13-2026-001`	Batch or lot identifier used for traceability.
2	`ProductName`	string / controlled vocabulary	`Pneumococcal Serotype 4`	Product or dosage-form name under evaluation.
3	`SaccharideContent_ug_per_ml`	decimal	`2.2`	Volume/dose used for load, limit or release calculation.
4	`ProteinContent_ug_per_ml`	decimal	`20.0`	Volume/dose used for load, limit or release calculation.
5	`FreePolysaccharide_Percent`	decimal	`3.5`	Controlled input parameter for deterministic QC rules.
6	`MolecularWeight_kDa`	decimal	`450.0`	Controlled input parameter for deterministic QC rules.
7	`CarrierProtein`	string / controlled vocabulary	`CRM197`	Biological/molecular component controlled as a CQA.

BatchNumber,ProductName,SaccharideContent_ug_per_ml,ProteinContent_ug_per_ml,FreePolysaccharide_Percent,MolecularWeight_kDa,CarrierProtein
CONJ-PCV13-2026-001,Pneumococcal Serotype 4,2.2,20.0,3.5,450.0,CRM197
CONJ-HIB-2026-002,Hib Conjugate,10.0,25.0,2.0,300.0,Tetanus Toxoid
CONJ-MEN-FAIL-003,Meningococcal C,5.0,15.0,8.5,200.0,CRM197

Input validation rules

ID	Field	Rule	Criticality
VR-001	`BatchNumber`	The field shall match an approved dictionary or accepted string representation.	High
VR-002	`ProductName`	The field shall match an approved dictionary or accepted string representation.	High
VR-003	`SaccharideContent_ug_per_ml`	The field shall match an approved dictionary or accepted string representation.	High
VR-004	`ProteinContent_ug_per_ml`	The field shall match an approved dictionary or accepted string representation.	Medium
VR-005	`FreePolysaccharide_Percent`	The field shall match an approved dictionary or accepted string representation.	Medium
VR-006	`MolecularWeight_kDa`	The field shall match an approved dictionary or accepted string representation.	Medium
VR-007	`CarrierProtein`	The field shall match an approved dictionary or accepted string representation.	Medium

FS — Functional Specification

ID	Function	Implementation
FS-001	CLI execution	Support execution modes: demo mode without arguments and production mode input.csv output.json.
FS-002	CSV import	Read input.csv in UTF-8/CSV-compatible format and validate header and expected columns.
FS-003	Schema validation	Check mandatory fields, column count, unknown key fields and empty mandatory values.
FS-004	Type conversion	Convert numeric, flag and text values; invalid format is recorded as a row-level error.
FS-005	Domain rule engine	Apply rules for Conjugate Vaccine Polysaccharide/Protein Ratio Quality Checker, including critical limits from the description and approved specification.
FS-006	Status aggregation	Produce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance.
FS-007	JSON export	Write output.json with detailed checks, source values, warnings, failures and critical findings.
FS-008	Audit support	Keep result structure suitable for review, deviation investigation and calculation reproduction.
FS-009	Integration contract	Support the scenario LIMS/ELN/MES → input.csv → utility → output.json → portal/admin review.
FS-010	Error handling	Return explicit messages for missing file, empty CSV, invalid schema, output write failure and invalid format.

Example output.json

{
  "utilityId": "conjugatevaccinepolysaccharideproteinratio-qualitychecker",
  "utilityFolder": "ConjugateVaccinePolysaccharideProteinRatio_QualityChecker",
  "package": "huvac",
  "overallStatus": "PASS|WARNING|FAIL",
  "sourceFile": "input.csv",
  "processedAtUtc": "2026-06-10T00:00:00Z",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "CONJ-PCV13-2026-001",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-001"
    },
    {
      "parameter": "ProductName",
      "value": "Pneumococcal Serotype 4",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-002"
    },
    {
      "parameter": "SaccharideContent_ug_per_ml",
      "value": "2.2",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-003"
    },
    {
      "parameter": "ProteinContent_ug_per_ml",
      "value": "20.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-004"
    },
    {
      "parameter": "FreePolysaccharide_Percent",
      "value": "3.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-005"
    },
    {
      "parameter": "MolecularWeight_kDa",
      "value": "450.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-006"
    },
    {
      "parameter": "CarrierProtein",
      "value": "CRM197",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-007"
    }
  ],
  "criticalFindings": [],
  "warnings": [],
  "audit": {
    "inputHash": "sha256:<calculated at runtime>",
    "rulesVersion": "<utility executable version>",
    "documentation": "ConjugateVaccinePolysaccharideProteinRatio_QualityChecker.documentation.html"
  }
}

Traceability matrix

URS	FS	Test	Evidence
URS-001	FS-001, FS-002	OQ-001	Verify execution and import of valid input.csv.
URS-002	FS-005, FS-006	OQ-004	Repeat the same dataset and compare output.json.
URS-003	FS-003, FS-004, FS-010	OQ-002, OQ-003	Verify missing columns and invalid types.
URS-004	FS-005, FS-006	OQ-004, PQ-001	Verify critical deviations on real/boundary data.
URS-005	FS-007, FS-009	OQ-005	Verify JSON schema and downstream-system suitability.
URS-006	FS-008	OQ-006	Verify identifiers and audit metadata.
URS-007	FS-008, FS-010	IQ-001, OQ-007	Verify documentation completeness and control evidence.
URS-008	FS-005, FS-008	PQ-002	Verify review workflow and no replacement of QA decision.

IQ/OQ/PQ test scenarios

ID	Scenario	Expected result
IQ-001	Verify executable, input.csv, documentation and checksum availability.	Delivery set is complete; version is recorded.
OQ-001	Valid sample row from input.csv.	PASS or acceptable WARNING according to rules.
OQ-002	Remove a mandatory CSV column.	Schema error or FAIL with missing-column reference.
OQ-003	Place a non-numeric value into a numeric field.	Type-conversion error with row/field reference.
OQ-004	Set a critical parameter outside the limit.	FAIL and critical finding.
OQ-005	Verify output.json structure.	All mandatory sections are present and JSON is valid.
OQ-006	Verify batch/sample traceability.	Input and result identifiers match.
PQ-001	Verify 3–5 real user batches/samples.	Result is confirmed by QC/QA review.
PQ-002	Verify deviation workflow and manual QA decision.	Utility supports review but does not replace approved decision.

QA/QC and change control

Do not rename columns without updating validator, documentation and test set.
Retain input.csv, output.json, executable version and checksum.
Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
Critical limits shall be verified against the approved specification, registration dossier and local SOPs.
The utility provides structured QC decision support; final release decision remains with QA/QP and approved procedures.

Included in packages

Biopharmaceuticals Extended QC Suite

Extended QC utility coverage for mAbs, biosimilars, proteins, insulins, vaccines, mRNA/LNP, HCP, sterile release, microbiology, water, cleanroom and stability workflows.

Open

Huvac — Human Vaccine QC Utilities

Huvac contains QC utilities for human vaccines: adjuvants, antigen potency, sterility, endotoxins, cold chain, mRNA controls, container closure and stability checks.

Open